Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung Cancer

von Halmos, Balazs, Pennell, Nathan A., Fu, Pingfu, Saad, Shumaila, Gadgeel, Shirish, Otterson, Gregory A., Mekhail, Tarek, Snell, Michael, Kuebler, J. Philip, Sharma, Neelesh, Dowlati, Afshin
Veröffentlicht in Oncologist (2015)

Phase I Trial of Fludarabine, Bortezomib and Rituximab for Relapsed and Refractory Indolent and Mantle Cell Non-Hodgkin Lymphoma

von Barr, Paul M., Fu, Pingfu, Lazarus, Hillard M., Horvath, Nancy, Gerson, Stanton L., Koc, Omer N., Bahlis, Nizar J., Snell, Michael R., Dowlati, Afshin, Cooper, Brenda W.
Veröffentlicht 2009